X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DM | 2024-09-06 | TRVI | Good Jennifer L | Pres, CEO | S - Sale+OE | $3.03 | -6,059 | 213,313 | -3% | -$18,371 | |||||
DM | 2024-09-03 | TRVI | Good Jennifer L | Pres, CEO | S - Sale+OE | $3.09 | -55,121 | 213,313 | -21% | -$170,193 | |||||
D | 2024-08-27 | TRVI | Meeker David P | Dir | S - Sale+OE | $2.93 | -4,555 | 352,489 | -1% | -$13,353 | |||||
D | 2024-08-19 | TRVI | Sciascia Thomas | Chief Scientific Officer | S - Sale+OE | $2.96 | -16,496 | 220,315 | -7% | -$48,883 | |||||
DM | 2024-08-14 | TRVI | Sciascia Thomas | Chief Scientific Officer | S - Sale+OE | $2.77 | -31,505 | 220,315 | -13% | -$87,228 | |||||
D | 2024-05-29 | TRVI | Sciascia Thomas | Chief Scientific Officer | S - Sale+OE | $2.55 | -53,368 | 214,433 | -20% | -$136,110 | |||||
D | 2024-05-22 | TRVI | Delfini Lisa | CFO | S - Sale+OE | $2.64 | -4,350 | 53,279 | -8% | -$11,485 | |||||
D | 2024-05-20 | TRVI | Good Jennifer L | Pres, CEO | S - Sale+OE | $2.86 | -25,037 | 213,313 | -11% | -$71,576 | |||||
D | 2024-05-10 | TRVI | Good Jennifer L | Pres, CEO | S - Sale+OE | $2.90 | -4,578 | 213,313 | -2% | -$13,276 | |||||
D | 2023-10-11 | TRVI | Delfini Lisa | CFO | S - Sale+OE | $2.02 | -785 | 35,901 | -2% | -$1,586 | |||||
D | 2023-09-11 | TRVI | Delfini Lisa | CFO | S - Sale+OE | $2.20 | -711 | 34,394 | -2% | -$1,564 | |||||
D | 2023-08-11 | TRVI | Delfini Lisa | CFO | S - Sale+OE | $2.36 | -682 | 32,814 | -2% | -$1,610 | |||||
D | 2023-07-11 | TRVI | Delfini Lisa | CFO | S - Sale+OE | $2.34 | -687 | 31,204 | -2% | -$1,608 | |||||
D | 2023-06-12 | TRVI | Delfini Lisa | CFO | S - Sale+OE | $2.64 | -610 | 29,599 | -2% | -$1,610 | |||||
D | 2023-05-11 | TRVI | Delfini Lisa | CFO | S - Sale+OE | $2.89 | -562 | 27,918 | -2% | -$1,624 | |||||
D | 2023-04-11 | TRVI | Delfini Lisa | CFO | S - Sale+OE | $1.84 | -840 | 26,189 | -3% | -$1,545 | |||||
D | 2023-03-13 | TRVI | Delfini Lisa | CFO | S - Sale+OE | $1.75 | -892 | 24,737 | -3% | -$1,564 | |||||
D | 2023-02-13 | TRVI | Delfini Lisa | CFO | S - Sale+OE | $2.45 | -8,474 | 23,338 | -27% | -$20,761 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |